Joyce Varughese

1.1k total citations
21 papers, 628 citations indexed

About

Joyce Varughese is a scholar working on Obstetrics and Gynecology, Oncology and Immunology and Allergy. According to data from OpenAlex, Joyce Varughese has authored 21 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Obstetrics and Gynecology, 8 papers in Oncology and 6 papers in Immunology and Allergy. Recurrent topics in Joyce Varughese's work include Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cell Adhesion Molecules Research (6 papers). Joyce Varughese is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cell Adhesion Molecules Research (6 papers). Joyce Varughese collaborates with scholars based in United States, Italy and India. Joyce Varughese's co-authors include Alessandro D. Santin, Peter E. Schwartz, Thomas Rutherford, Emiliano Cocco, Sërgio Pecorelli, Stefania Bellone, Joyce Bischoff, Ying Yu, John B. Mulliken and Lawrence F. Brown and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

Joyce Varughese

21 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joyce Varughese United States 15 327 203 123 117 96 21 628
Frédéric Kridelka Belgium 17 252 0.8× 220 1.1× 127 1.0× 82 0.7× 131 1.4× 53 721
Ilaria Betella Italy 12 342 1.0× 191 0.9× 130 1.1× 143 1.2× 42 0.4× 27 620
Raquel Bratos Spain 8 327 1.0× 116 0.6× 222 1.8× 229 2.0× 64 0.7× 13 609
A P Kudelka United States 13 169 0.5× 184 0.9× 140 1.1× 176 1.5× 91 0.9× 24 598
M. Combe France 11 249 0.8× 76 0.4× 67 0.5× 197 1.7× 109 1.1× 22 477
Masafumi Yasunaga Japan 16 246 0.8× 104 0.5× 159 1.3× 118 1.0× 272 2.8× 86 636
D. Paraïso France 14 272 0.8× 149 0.7× 203 1.7× 401 3.4× 216 2.3× 35 689
Mona Ridderheim Sweden 13 307 0.9× 197 1.0× 143 1.2× 391 3.3× 137 1.4× 26 825
P. Hirnle Germany 11 250 0.8× 91 0.4× 91 0.7× 57 0.5× 78 0.8× 31 454
Laura Ardighieri Italy 16 181 0.6× 176 0.9× 147 1.2× 200 1.7× 137 1.4× 43 616

Countries citing papers authored by Joyce Varughese

Since Specialization
Citations

This map shows the geographic impact of Joyce Varughese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce Varughese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce Varughese more than expected).

Fields of papers citing papers by Joyce Varughese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce Varughese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce Varughese. The network helps show where Joyce Varughese may publish in the future.

Co-authorship network of co-authors of Joyce Varughese

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce Varughese. A scholar is included among the top collaborators of Joyce Varughese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce Varughese. Joyce Varughese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varughese, Joyce, et al.. (2020). Malignant recurrence of Female Adnexal Tumor of Probable Wolffian Origin (FATWO). Gynecologic Oncology Reports. 34. 100666–100666. 3 indexed citations
2.
Matthews, Robert, et al.. (2020). Fluorodeoxyglucose positron-emission tomography-magnetic resonance hybrid imaging: An emerging tool for staging of cancer of the uterine cervix. SHILAP Revista de lepidopterología. 20(2). 150–155. 4 indexed citations
3.
Greenberg, Patricia, et al.. (2020). Accuracy in Referrals to Gynecologic Oncologists Based on Clinical Presentation for Ovarian Mass. Diagnostics. 10(2). 106–106. 5 indexed citations
4.
Varughese, Joyce, et al.. (2019). Uterine torsion with necrosis of bilateral adnexa in a postmenopausal woman. BMJ Case Reports. 12(6). e229311–e229311. 8 indexed citations
5.
Menderes, Gulden, Salvatore Lopez, Chanhee Han, et al.. (2018). Mechanisms of resistance to HER2-targeted therapies in HER2-amplified uterine serous carcinoma, and strategies to overcome it.. PubMed. 26(141). 39–50. 24 indexed citations
6.
Varughese, Joyce, et al.. (2013). Syndrome of Inappropriate Antidiuretic Hormone after vinorelbine treatment. Journal of Oncology Pharmacy Practice. 19(4). 380–383. 1 indexed citations
7.
Guzzo, Federica, Stefania Bellone, Natália Buza, et al.. (2012). HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas. International Journal of Gynecological Pathology. 31(3). 211–221. 33 indexed citations
8.
Bignotti, Eliana, Antonella Ravaggi, Chiara Romani, et al.. (2011). Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid Carcinoma. International Journal of Gynecological Cancer. 21(9). 1613–1621. 31 indexed citations
9.
Cocco, Emiliano, Joyce Varughese, Natália Buza, et al.. (2011). Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor. Clinical & Experimental Metastasis. 28(7). 689–700. 33 indexed citations
10.
11.
12.
13.
ElSahwi, Karim, Jessica L. Illuzzi, Joyce Varughese, et al.. (2011). A survey of gynecologic oncologists regarding the End-of-Life discussion: A pilot study. Gynecologic Oncology. 124(3). 471–473. 18 indexed citations
14.
Bellone, Marta, Emiliano Cocco, Joyce Varughese, et al.. (2011). Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti – αV-Integrin Antibody. International Journal of Gynecological Cancer. 21(6). 1084–1090. 11 indexed citations
15.
Guzzo, Federica, Luisa Carrara, Joyce Varughese, et al.. (2011). Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. Journal of Experimental & Clinical Cancer Research. 30(1). 106–106. 40 indexed citations
16.
Varughese, Joyce, Emiliano Cocco, Stefania Bellone, et al.. (2011). Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. American Journal of Obstetrics and Gynecology. 205(6). 567.e1–567.e7. 39 indexed citations
17.
Casagrande, Francesca, Emiliano Cocco, Stefania Bellone, et al.. (2011). Eradication of chemotherapy‐resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin. Cancer. 117(24). 5519–5528. 55 indexed citations
18.
Varughese, Joyce, Pei Hui, Lingeng Lu, Herbert Yu, & Peter E. Schwartz. (2011). Clear Cell Cancer of the Uterine Corpus: The Association of Clinicopathologic Parameters and Treatment on Disease Progression. Journal of Oncology. 2011. 1–6. 20 indexed citations
19.
Varughese, Joyce & Susan Richman. (2010). Cancer care inequity for women in resource-poor countries.. PubMed. 3(3). 122–32. 44 indexed citations
20.
Yu, Ying, Joyce Varughese, Lawrence F. Brown, John B. Mulliken, & Joyce Bischoff. (2001). Increased Tie2 Expression, Enhanced Response to Angiopoietin-1, and Dysregulated Angiopoietin-2 Expression in Hemangioma-Derived Endothelial Cells. American Journal Of Pathology. 159(6). 2271–2280. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédéric Kridelka Breakdown of academic impact, for papers by Ilaria Betella Breakdown of academic impact, for papers by Raquel Bratos Breakdown of academic impact, for papers by A P Kudelka Breakdown of academic impact, for papers by M. Combe Breakdown of academic impact, for papers by Masafumi Yasunaga Breakdown of academic impact, for papers by D. Paraïso Breakdown of academic impact, for papers by Mona Ridderheim Breakdown of academic impact, for papers by P. Hirnle Breakdown of academic impact, for papers by Laura Ardighieri
Rankless by CCL
2026